Pharma sector


India is a land of opportunities

Invest in Indian Pharmaceutical Industry

 

The Pharmaceutical industry in India is the world's third-largest in terms of volume and stands 13th  in terms of value. India is now among the top five pharmaceutical emerging markets globally and is a front runner in a wide range of specialties involving complex drugs' manufacture, development, and technology. The total market size of Rs. 1,233 bn includes domestic consumption market of Rs.600 bn (contributing ~48.6%) and the exports market being Rs. 633 bn (contributing ~51.4%). The industry grew at a CAGR of ~12.5% during the past five years and is expected to growth at a robust CAGR of 15.1% during FY2012-17 given huge export potential coupled with steady growth in the domestic formulation market.

As a highly organised sector, the number of pharmaceutical companies are increasing their operations in India. The industry is expected to touch US$ 35.9 billion by 2016. The cumulative drugs and pharmaceuticals sector has attracted foreign direct investments (FDI) worth US$ 11,304.91 million during April 2000 to April 2013, according to the latest data published by Department of Industrial Policy and Promotion (DIPP). Pharmaceutical exports from the country during 2012-13 stood at US$14.6 billion, up from US$13.2 billion the previous year, as per P V Appaji, Director General, Pharmexcil.

 

Diagnostics Outsourcing/ Clinical Trials

India is fast becoming the preferred destination for high-end pathology and diagnostic services. The highly fragmented diagnostics and pathology labs market in India is pegged at US$ 3.4 billion, according to a report by PricewaterhouseCoopers.

An increasing number of hospitals from the UK, US, Middle East and neighbouring countries are tying up with Indian diagnostic centres to conduct laboratory tests. The Indian diagnostic services market is expected to grow at a compound annual growth rate (CAGR) of around 26 per cent during 2012-2015 on back of huge investments, fast expansion into tier II & III cities, and strong government support strengthening the healthcare infrastructure in the country.

According to RNCOs research report “Booming Clinical Trials Market in India”, the number of clinical studies by domestic and global players has sharply risen. India, over the last decade, has developed significant capabilities in clinical trials, along with certain capabilities in project management and data management.According to RNCOs research report “Booming Clinical Trials Market in India”, the number of clinical studies by domestic and global players has sharply risen. India, over the last decade, has developed significant capabilities in clinical trials, along with certain capabilities in project management and data management.

Growth in the domestic pharma market will be driven by increase in the penetration of medical facilities, increase in the prevalence of chronic diseases, rising per capita income and increase in the health insurance coverage. Growth in the exports of pharmaceutical products from India will be driven by patent expiries of the major branded drugs across the world, particularly in the US market.

The another opportunity in pharmacy sector that the foreigners can establish branch office or export house as 100 % owned company or subsidiary in India and get manufactured the required pharmaceutical products from Indian company by paying the job work charges and raw materials in their own brand name. The parties not required to go for establishing manufacturing plant.   

Government Initiatives

Currently, 100 per cent FDI in pharma sector is permitted through automatic approval route in the new projects but the foreign investment in the existing pharma companies requires FIPB approval.

We provide complete consultancy services to setup Pharmaceutical industry in India under Foreign Direct Investment regulations.

Services offered by us:

 

Formation of company. 

Make arrangement of land with clear legal title considering using for Pharmaceutical project.  

Clearances, permissions, licenses, NOCs, etc., as required by the government & other authorities concerned. 

Establishment of manufacturing plant of bulk drug or pharmaceutical products.

Formation of export house for Pharmaceutical products.

Third-party manufacturing arrangement.

Trade mark, patent and other intellectual property services.

All legal consultancy and technical services required in starting and continuation of business operation in India.

 

Business offers and proposals: Project and proposals

 

Upload your requirement and proposal: Upload Requirement


 

 

 

 

Copy right @ ansarilawin.com All Rights Reserved.